Original-Research: Aspermont Ltd (von GBC AG): Buy
^
Original-Research: Aspermont Ltd - von GBC AG
Einstufung von GBC AG zu Aspermont Ltd
Unternehmen: Aspermont Ltd
ISIN: AU000000ASP3
Anlass der Studie: Research (Note)
Empfehlung: Buy
Kursziel: 0.08 AUD
Kursziel auf Sicht von: 31.12.2023
Letzte Ratingänderung:
Analyst: Julien Desrosiers, Matthias Greiffenberger
Growth even facing headwinds market conditions. Renowned top executive and
management hiring. Forecast focus on return to double digit growth.
Facing headwinds but growing. The revenues are up 1% YoY, reaching $9.36m
AUD. Revenues are in line with company's guidance.
Increased net liquidity asset. The company has a net liquidity position of
4.4m, up from HY 2022 $3.9m.
HY gross margin, lower but healthy. The company's gross margin has
decreased to 63.56% for the HY 2023.
Privileged position. While the entire sector is seeing important diminution
in publicity revenues and overall revenues, the company's revenues are
still growing.
Accountable. The company's guidance has proven right once again. The
management has a core understanding of their business and market
conditions.
Enviable Hiring. The company continues to hire top talent from different
bluechip companies, building a dream team. The fruit of this hiring should
be borne soon enough with implementation and scaling of new and existing
products.
Operational Agility. Decentralised structure and scalable human resources
for rapid launch or products while controlling investment risk as seen in
the increase of their net asset liquidity.
Continued double digit growth. The company guidance is to reach a double
digit growth in revenues for the FY2023.
Based on our DCF model, we maintain our Buy rating with a price target at
0.08 AUD (0.05 EUR) (previously: 0.10 AUD (0.07 EUR)) per share.
Die vollständige Analyse können Sie hier downloaden:
http://www.more-ir.de/d/27245.pdf
Kontakt für Rückfragen
GBC AG
Halderstraße 27
86150 Augsburg
0821 / 241133 0
research@gbc-ag.de
++++++++++++++++
Offenlegung möglicher Interessenskonflikte nach § 85 WpHG und Art. 20 MAR Beim oben analysierten Unternehmen ist folgender möglicher Interessenkonflikt gegeben: (5a,7,11); Einen Katalog möglicher Interessenkonflikte finden Sie unter:
http://www.gbc-ag.de/de/Offenlegung
+++++++++++++++
Date and time of completion of this research: 21.06.2023 16:00
Date and time of first distribution: 22.06.2023 10:00
-------------------übermittelt durch die EQS Group AG.-------------------
Für den Inhalt der Mitteilung bzw. Research ist alleine der Herausgeber bzw.
Ersteller der Studie verantwortlich. Diese Meldung ist keine Anlageberatung
oder Aufforderung zum Abschluss bestimmter Börsengeschäfte.
°